BCB Bancorp closes $98M equity raise after full over-allotment exercise
- BCB Bancorp closed public offering of 12.65 million shares at $7.75 each
- Full exercise of over-allotment option raised aggregate gross proceeds of $98.04 million
- Proceeds will support bank capital and address legacy credit challenges in Q3FY26
- Company expects Q3 net loss of $126.2M-$136.1M due to $112M-$120M credit loss provision
- Portfolio includes $210M in problem loans and $69M in cannabis-related loans for sale
*this image is generated using AI for illustrative purposes only.
BCB Bancorp Inc (NASDAQ: BCBP) has closed its underwritten public offering of 12,650,000 shares of common stock at $7.75 per share. The deal generated aggregate gross proceeds of approximately $98.04 million before deducting underwriting discounts and commissions. The closing followed the full exercise of the underwriter’s option to purchase an additional 1,650,000 shares.
Piper Sandler & Co acted as the sole book-running manager for the transaction. Arnold & Porter Kaye Scholer LLP advised the company, while Kilpatrick Townsend & Stockton LLP advised Piper Sandler.
Capital Raise Details
The proceeds from the equity issuance will fund general corporate purposes. Key uses include maintaining liquidity, funding working capital, supporting bank capital, and reducing debt. Management aims to maintain capital and liquidity ratios at acceptable levels for both the holding company and BCB Community Bank. The capital raise supports the bank’s strategy to address legacy credit challenges identified in its Q3FY26 guidance, including the expected disposition of identified potential problem loans.
| Offering Detail | Value |
|---|---|
| Shares Offered (Base) | 11,000,000 |
| Over-allotment Shares | 1,650,000 |
| Total Shares Sold | 12,650,000 |
| Price Per Share | $7.75 |
| Gross Proceeds | $98.04 million |
| Closing Date | September 18, 2026 |
| Underwriter | Piper Sandler & Co |
Context: Q3FY26 Loss Expectations
The capital raise coincides with BCB Bancorp’s expectation of a net loss between $126.2 million and $136.1 million for the third quarter of 2026. The loss is driven primarily by a provision for credit losses estimated between $112 million and $120 million. This provision includes an expected pre-tax loss of $87 million related to the anticipated sale of approximately $210 million in problem loans.
Additionally, the company recorded a valuation allowance against its entire net deferred tax asset balance of approximately $50 million. This accounting adjustment reflects cumulative losses that make realization improbable.
Loan Portfolio Restructuring
Management identified a portfolio of criticized loans for sale, comprising:
- Commercial and multifamily real estate loans: $183.4 million unpaid principal balance
- Commercial and industrial loans: $16.7 million unpaid principal balance
- Construction loans: $9.8 million unpaid principal balance
Most loans carry internal risk ratings of Special Mention or Substandard. The bank has received non-binding indications of interest from multiple prospective purchasers covering the entire $210 million aggregate principal balance. Sales are expected to close in the third quarter.
Strategic Divestitures
BCB Community Bank commenced marketing for the potential sale of its business lines focused on cannabis-related customers. This includes:
- Cannabis-related loans: $69 million aggregate unpaid principal balance
- Deposits from cannabis-related businesses: $70 million aggregate balance
These assets are expected to be transferred to held-for-sale in the third quarter alongside approximately $27 million in commercial real estate loans exhibiting credit weakness.
What the Numbers Show
The final equity raise of $98.04 million, boosted by the full exercise of the over-allotment option, provides a larger liquidity buffer against the anticipated Q3 net loss of up to $136.1 million. While the capital injection does not fully offset the projected quarterly deficit, it enhances the bank’s ability to absorb the $87 million impairment charge related to problem loan sales without breaching regulatory capital requirements. The simultaneous execution of the completed equity raise and portfolio cleanup suggests a strategic pivot toward stabilizing the balance sheet after addressing legacy asset quality issues.
How will the full exercise of the over-allotment option impact existing shareholders' dilution compared to the base offering, and what is management's plan to mitigate long-term EPS pressure?
What specific criteria will BCB Bancorp use to select a buyer for the cannabis-related business lines, and how might the transfer of $70 million in deposits affect the bank's net interest margin post-sale?
Given the $50 million valuation allowance against deferred tax assets, what operational milestones must the bank achieve to reverse this write-off and realize those tax benefits in future quarters?
20
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
